PMID- 21195169 OWN - NLM STAT- MEDLINE DCOM- 20110506 LR - 20211203 IS - 1873-4596 (Electronic) IS - 0891-5849 (Print) IS - 0891-5849 (Linking) VI - 50 IP - 5 DP - 2011 Mar 1 TI - Cadmium induction of reactive oxygen species activates the mTOR pathway, leading to neuronal cell death. PG - 624-32 LID - 10.1016/j.freeradbiomed.2010.12.032 [doi] AB - Cadmium (Cd), a highly toxic environmental pollutant, induces neurodegenerative diseases. Recently we have demonstrated that Cd induces neuronal apoptosis in part through activation of the mammalian target of rapamycin (mTOR) pathway. However, the underlying mechanism is unknown. Here we show that Cd induces the generation of reactive oxygen species (ROS) by upregulating the expression of NADPH oxidase 2 and its regulatory proteins (p22(phox), p67(phox), p40(phox), p47(phox), and Rac1) in PC12 and SH-SY5Y cells. Cd induction of ROS contributed to the activation of mTOR signaling, as pretreatment with N-acetyl-l-cysteine (NAC), a ROS scavenger, prevented this event. Further studies reveal that Cd induction of ROS increased phosphorylation of the type I insulin-like growth factor receptor (IGFR) beta subunit, which was abrogated by NAC. Wortmannin, a phosphoinositide 3'-kinase (PI3K) inhibitor, partially attenuated Cd-induced phosphorylation of Akt, p70 S6 kinase 1, and eukaryotic initiation factor 4E-binding protein 1, as well as apoptosis of the neuronal cells. In addition, overexpression of wild-type phosphatase and tensin homologue deleted on chromosome 10 (PTEN) or pretreatment with aminoimidazole carboxamide ribonucleotide, an AMP-activated protein kinase (AMPK) activator, partially prevented Cd-induced ROS and activation of the mTOR pathway, as well as cell death. The results indicate that Cd induction of ROS activates mTOR signaling, leading to neuronal cell death, in part by activating the positive regulators IGFR/PI3K and by inhibiting the negative regulators PTEN/AMPK. The findings suggest that inhibitors of PI3K and mTOR, activators of AMPK, or antioxidants may be exploited for the prevention of Cd-induced neurodegenerative diseases. CI - 2010 Elsevier Inc. All rights reserved. FAU - Chen, Long AU - Chen L AD - Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, LA 71130-3932, USA. FAU - Xu, Baoshan AU - Xu B FAU - Liu, Lei AU - Liu L FAU - Luo, Yan AU - Luo Y FAU - Zhou, Hongyu AU - Zhou H FAU - Chen, Wenxing AU - Chen W FAU - Shen, Tao AU - Shen T FAU - Han, Xiuzhen AU - Han X FAU - Kontos, Christopher D AU - Kontos CD FAU - Huang, Shile AU - Huang S LA - eng GR - R01 CA115414/CA/NCI NIH HHS/United States GR - R01 CA115414-04/CA/NCI NIH HHS/United States GR - CA115414/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20101230 PL - United States TA - Free Radic Biol Med JT - Free radical biology & medicine JID - 8709159 RN - 0 (Androstadienes) RN - 0 (Carrier Proteins) RN - 0 (Eif4ebp1 protein, rat) RN - 0 (Environmental Pollutants) RN - 0 (Intracellular Signaling Peptides and Proteins) RN - 0 (Phosphoinositide-3 Kinase Inhibitors) RN - 0 (Phosphoproteins) RN - 0 (Reactive Oxygen Species) RN - 0 (Receptors, Somatomedin) RN - 0 (neutrophil cytosol factor 40K) RN - 0 (neutrophil cytosol factor 67K) RN - 00BH33GNGH (Cadmium) RN - EC 1.6.3.- (NADPH Oxidases) RN - EC 1.6.3.1 (CYBA protein, human) RN - EC 1.6.3.1 (neutrophil cytosolic factor 1) RN - EC 2.7.11.1 (Ribosomal Protein S6 Kinases, 70-kDa) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 3.6.5.2 (rac1 GTP-Binding Protein) RN - WYQ7N0BPYC (Acetylcysteine) RN - XVA4O219QW (Wortmannin) SB - IM MH - Acetylcysteine/analysis MH - Androstadienes/pharmacology MH - Animals MH - Apoptosis/*drug effects MH - Cadmium/*toxicity MH - Carrier Proteins/metabolism MH - Environmental Pollutants/*toxicity MH - Gene Expression Regulation MH - Humans MH - Intracellular Signaling Peptides and Proteins MH - NADPH Oxidases/genetics/physiology MH - Neurodegenerative Diseases/chemically induced/metabolism/pathology MH - Neurons/*drug effects/pathology MH - PC12 Cells MH - Phosphoinositide-3 Kinase Inhibitors MH - Phosphoproteins/genetics/metabolism MH - Phosphorylation MH - Rats MH - Reactive Oxygen Species/*metabolism MH - Receptors, Somatomedin/genetics MH - Ribosomal Protein S6 Kinases, 70-kDa/metabolism MH - TOR Serine-Threonine Kinases/*metabolism MH - Wortmannin MH - rac1 GTP-Binding Protein/genetics PMC - PMC3032035 MID - NIHMS262082 EDAT- 2011/01/05 06:00 MHDA- 2011/05/07 06:00 PMCR- 2012/03/01 CRDT- 2011/01/04 06:00 PHST- 2010/09/10 00:00 [received] PHST- 2010/12/04 00:00 [revised] PHST- 2010/12/21 00:00 [accepted] PHST- 2011/01/04 06:00 [entrez] PHST- 2011/01/05 06:00 [pubmed] PHST- 2011/05/07 06:00 [medline] PHST- 2012/03/01 00:00 [pmc-release] AID - S0891-5849(10)01464-4 [pii] AID - 10.1016/j.freeradbiomed.2010.12.032 [doi] PST - ppublish SO - Free Radic Biol Med. 2011 Mar 1;50(5):624-32. doi: 10.1016/j.freeradbiomed.2010.12.032. Epub 2010 Dec 30.